What is Behcet’s Syndrome? By: Freya Howe


 Behcet’s syndrome (also known as Behcet’s disease) is an Autoinflammatory chronic

illness, resulting in the inflammation of blood vessels and tissues. Behcet’s affects

roughly 10.3 people per 100,000 and is far more common in areas such as the

Middle East, Far East, and the Mediterranean. In countries like Türkiye, Iran, and

Japan. Behcet’s is a poorly understood disease that has debilitating effects on

people's lives, which is why research and advocacy are such important things.

The cause of Behcet’s disease is currently unknown; however, both genetic and

environmental factors seem to contribute. Behcet’s most commonly affects those in

specific ethnic groups, with Türkiye reporting the highest number of cases. However,

a person’s environment also influences their likelihood of developing Behcet’s; those

from an at-risk ethnic group who have moved from their home countries elsewhere

have a lower risk of developing this disease.

Behcet’s presents itself through a variety of symptoms which are shared by

numerous other conditions; this contributes to its difficulty in diagnosing. Patients

experience: oral and genital ulcers, inflamed eyes, blurred vision, headaches, acne-

like spots, and swollen joints. These symptoms are often extremely painful, resulting

in blindness, difficulty eating, arthritis, fatigue, and in rare cases nervous issues.

Patients report feeling lonely and isolated due to managing their illness, often losing

their confidence, income, and close relationships they had.

Behcet’s is a difficult disease to diagnose as there is no single test to identify it.

Doctors may use blood tests, urine tests, or skin biopsies to look for signs of the

condition, or to rule out other causes. Because of the extensive process, patients are

often delayed in diagnosis.

Currently, there is no cure for Behcet’s disease; however, the symptoms can be

managed to improve the affected person's quality of life with medicine that reduces the

inflammation of the affected areas. These include steroids – anti-inflammatory

medicines, immunosuppressants – reducing the activity of the immune system, and

biological therapies – which target the biological processes involved with

inflammation. Treatment options are highly individualized as symptoms and

circumstances vary from person to person.

Current research focuses on finding the most effective biological therapy to manage

Behcet’s disease, as well as gaining high-quality evidence of the effects of these

therapies, to help patients make an informed choice on which treatment to

receive.

It’s important that people understand this condition to advocate for and

empathise with those who are affected by this disease. People with Behcet’s often

experience mental health issues due to their illness; it can impact someone’s job,


relationships, and daily life. Many find it difficult to function properly in their day-to-

day lives, experiencing debilitating pain due to their symptoms. Advocacy for those

with Behcet’s is incredibly important as it brings more awareness to the condition,

letting patients know they’re not alone. More access to resources educating

someone on Behcet’s reduces misconceptions people have about the disease and

allows a person to recognise their symptoms sooner and receive care.

In summary, Behcet’s is a serious and debilitating disease which can completely

reshape a patient’s life; advocacy, education, and more research are essential to

inform people of this condition and ensure those affected receive adequate care.

Sources:

Behçets. (2026). Bad.Org.Uk. https://www.bad.org.uk/pils/behcets

NHS Choices. (2019). Overview


-

Behçet’s disease. NHS. https://www.nhs.uk/conditions/behcets-disease/

Wales Online Support Group Meeting. (2024, May 9). Behçet’s UK.

https://behcetsuk.org/about-behcets/

Moots, R. J., Fortune, F., Jackson, R., Thornburn, T., Morgan, A., Carr, D. F.,

Murray, P. I., Wallace, G. R., & Situnayake, D. (2025). Infliximab vs interferon-α

in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S

randomized controlled trial. Rheumatology (Oxford, England), 64(5),

2882–2891. https://doi.org/10.1093/rheumatology/keae585

Comments

Post a Comment

Popular posts from this blog

Understanding Ehlers-Danlos Syndrome (EDS) By: Zella Shanks (Current Campaign)

Image
  Introduction   What is Ehlers-Danlos Syndrome (EDS)? Ehlers-Danlos Syndrome, also known as EDS, is a group of genetic disorders that affect the body’s connective tissues. Connective tissue is found almost everywhere in the body and helps hold everything together, including your own skin, joints, muscles, and blood vessels. People that have Ehlers-Danlos Syndrome have problems with collagen, which is one of the many main proteins that gives connective tissues its strength and flexibility. When collagen doesn’t work the way it’s supposed to, the body’s tissues become weaker and more likely to stretch or to get injured. Why Is It Important?    Even though EDS isn’t very well known, it can have a huge effect on someone’s everyday life. Many people deal with ongoing pain, fatigue, joint injuries, and other symptoms that can make normal activities more difficult. While there isn’t a cure yet, getting diagnosed early and learning how to manage the condition can ...
Read more

Uncovering the Clinical Characterization and Mechanisms of Fibrodysplasia Ossificans Progressiva (FOP) By: Sharen Rego

Image
 Introduction Fibrodysplasia Ossificans Progressiva or FOP is an exceedingly rare, yet severely disabling genetic disorder, characterized by the abnormal formation of bone tissue outside of the normal human skeleton (heterotopic ossification). This can occur within soft tissues like the skeletal muscles, tendons, and ligaments. With an estimated one in two million people affected globally, FOP represents one of the most complex genetic conditions known to modern medicine. Raising awareness for this disorder is crucial, as early symptoms are often misdiagnosed as cancer, leading to harmful medical interventions like biopsies or routine muscle injections which trigger irreversible bone growth. Main Body At the cellular level, FOP is caused by a specific mutation in the ACVR1 gene located on chromosome 2. This gene provides instructions for making a specialized receptor protein that controls when and where the body builds bone tissue (such as during fetal development or when healing a...
Read more

Understanding Cystic Fibrosis

Image
Blog written by Alyza Kour - Reasearch Lead of Teen Med Spot   Mucus in our body is more than just “gross stuff” coming out our nose when we have a cold, it’s actually a vital protective layer. Its job is to line our lungs, digestive tract, and other organs to keep them moist and to trap dust, bacteria, or virusese so your body can get rid of them. Healthy mucus is thin, slippery, and water (Think of it like a layer of liquid soap). ( Cleveland Clinic ) What is cystic fibrosis? It is a genetic disease that causes sticky, thick mucus to build up in your organs (Lungs, Digestive System, Pancreas), blocking and damaging them. ( Cleveland Clinic.org ) What causes cystic fibrosis? Changes to the CFTR gene - called variants or mutations - cause cystic fibrosis. CFTR makes a protein that works as an ion channel on the surface of a cell. Ion channels are like gates in a cell’s membrane that allow certain molecules to pass through. Think of this protein as a “gate” for chloride ions (sa...
Read more